OpenEvidence adds ACP clinical guidance through a licensing deal
Medical AI needs dependable reference material as well as capable models.

Medical AI needs dependable reference material as well as capable models.
What happened
OpenEvidence and the American College of Physicians announced a licensing agreement covering ACP clinical guidance and content from Annals of Internal Medicine. Financial terms were not disclosed. The agreement is separate from OpenEvidence's earlier education-platform launch and rheumatology partnership.
Why it matters
Access to established clinical material can strengthen the evidence available inside a decision-support product. It also makes content partnerships an important part of the product's development.
The bigger picture
A licensing agreement is not clinical validation. Accuracy, appropriate interpretation and patient outcomes need their own evidence, with clinicians retaining responsibility for care decisions.
